2023
DOI: 10.1002/jcsm.13244
|View full text |Cite
|
Sign up to set email alerts
|

Fatty acid amides as potential circulating biomarkers for sarcopenia

Abstract: Background Sarcopenia is characterized by a progressive decrease in skeletal muscle mass and function with age. Given that sarcopenia is associated with various metabolic disorders, effective metabolic biomarkers for its early detection are required. We aimed to investigate the metabolic biomarkers related to sarcopenia in elderly men and perform experimental studies using metabolomics. Methods Plasma metabolites from 142 elderly men, comprising a sarcopenia group and an age-matched control group, were measure… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…The participants for this study were selected from the Veterans Health Service Medical Center (VHSMC) sarcopenia cohort, which consisted of individuals with and without sarcopenia who visit the Endocrinology Department of the VHSMC in Seoul, Korea, between July 2020 and December 2020 (IRB No. 2020-02-015) [19]. The study design received approval from the Institutional Review Board (IRB No.…”
Section: Participants and Study Designmentioning
confidence: 99%
“…The participants for this study were selected from the Veterans Health Service Medical Center (VHSMC) sarcopenia cohort, which consisted of individuals with and without sarcopenia who visit the Endocrinology Department of the VHSMC in Seoul, Korea, between July 2020 and December 2020 (IRB No. 2020-02-015) [19]. The study design received approval from the Institutional Review Board (IRB No.…”
Section: Participants and Study Designmentioning
confidence: 99%